For sales

Highlights from the Week of 27th July – 03rd August in the world of pharma and healthcare!

Highlights from the Week of 27th July 2026 - 03rd August 2026 ( FDA, Approval ) FDA approves Novartis' PLUVICTO in combination with an ARPI to treat metastatic hormone-sensitive prostate cancer ( EU, Approval ) EC approves AstraZeneca and Daiichi Sankyo's DATROWAY as monotherapy to treat adults with unresectable or metastatic TNBC ( EU, Approval ) Pfizer and BioNTech gets marketing authorization from the EC for the 2026-2027 COVID-19 vaccine formulation to prevent COVID-19 in individuals 6 months of age and older ( Health Canada, Approval ) Biocon receives Health Canada approval for the YESINTEK autoinjector 45 mg/0.05 mL and 90 mg/mL, allowing customized treatment approaches for psoriasis Pg 1/3 All logos and trademarks remain the intellectual properties of their respective owners
Download

Connect with us

Please fill in the information below, and we'll get back to you.